Non-stimulants face uphill battle to penetrate ADHD market despite lower abuse potential: GlobalData Read more
AbbVie’s $10.1 bn Immunogen deal fortifies oncology portfolio, signals big pharma’s ADC investment surge: GlobalData Read more
Pharma contract manufacturing sees historic surge amidst inflation and investment challenges: GlobalData Read more